Randomized Controlled Trial of Intravitreal Ranibizumab Versus Standard Grid Laser for Macular Edema Following Branch Retinal Vein Occlusion
Authors:
- 1 January 2014
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 157 (1) , 237-247.e1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III StudyOphthalmology, 2011
- Antagonism of Vascular Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year OutcomesOphthalmology, 2010
- Initial Visual Acuity Is an Important Prognostic Factor in Patients with Branch Retinal Vein OcclusionOphthalmic Research, 2010
- Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein OcclusionOphthalmology, 2010
- The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and AustraliaOphthalmology, 2010
- Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with RanibizumabOphthalmology, 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with BevacizumabInvestigative Ophthalmology & Visual Science, 2009
- Interventions for Branch Retinal Vein OcclusionOphthalmology, 2007
- Vascular endothelial growth factor upregulation in human central retinal vein occlusion11The authors have no proprietary interest in any of the materials used in this study.Ophthalmology, 1998